Novo Nordisk to initiate study assessing CagriSema vs Tirzepatide US$ 22.60 Min. order: 1 piece ★★★★★ 4.5 (85 reviews) Sold : Login>>
Novo Nordisk flags Cagrilintide promise in hunt for next obesity drug US$ 28.21 Min. order: 1 piece ★★★★★ 4.5 (95 reviews) Sold : Login>>
Novo Nordisk Files NDA for CagriSema, Novel GLP-1-amylin Combination for Chronic Weight Management US$ 29.56 Min. order: 1 piece ★★★★★ 4.0 (201 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 22.07 Min. order: 1 piece ★★★★★ 4.8 (104 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 23.48 Min. order: 1 piece ★★★★★ 4.8 (61 reviews) Sold : Login>>